Liminal BioSciences Inc - Company Profile
Powered by 
All the sales intelligence you need on Liminal BioSciences Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Liminal BioSciences Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Liminal BioSciences Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Liminal BioSciences Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Liminal BioSciences Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Bruce Pritchard
Chief Executive Officer Senior ManagementMr. Bruce Prichard has been the Chief Executive Officer of the company since 2020. Prior to this, he served as the Chief Operating Officer and Chief Financial Officer of the company. Previously, he served as the Senior Director for CV Therapeutics.
Marie Iskra
Secretary; General Counsel Senior ManagementGary Bridger
Interim Chief Scientific Officer Senior ManagementDr. Gary Bridger is the Interim Chief Scientific Officer of the company. Prior to this, he served as the Executive Vice President of Research and Development at Xenon Pharmaceuticals Inc. Previously, Dr. Bridger served as the Senior Vice President of Research and Development at Genzyme Corporation.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer